Franz von Nussbaum

3.5k total citations · 1 hit paper
59 papers, 2.0k citations indexed

About

Franz von Nussbaum is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Franz von Nussbaum has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 18 papers in Oncology and 17 papers in Pharmacology. Recurrent topics in Franz von Nussbaum's work include Microbial Natural Products and Biosynthesis (16 papers), Cancer-related Molecular Pathways (11 papers) and Antibiotic Resistance in Bacteria (7 papers). Franz von Nussbaum is often cited by papers focused on Microbial Natural Products and Biosynthesis (16 papers), Cancer-related Molecular Pathways (11 papers) and Antibiotic Resistance in Bacteria (7 papers). Franz von Nussbaum collaborates with scholars based in Germany, United States and France. Franz von Nussbaum's co-authors include Dieter Häbich, Michael Brands, Stefan Weigand, Berthold Hinzen, Samuel J. Danishefsky, Dominik Mumberg, Gerhard Siemeister, Wölfgang Steglich, Roderich D. Süßmuth and Philip Lienau and has published in prestigious journals such as Angewandte Chemie International Edition, Cancer Research and Clinical Cancer Research.

In The Last Decade

Franz von Nussbaum

58 papers receiving 2.0k citations

Hit Papers

Antibacterial Natural Products in Medicinal Chemistry—Exo... 2006 2026 2012 2019 2006 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
    2006 530 citations Franz von Nussbaum, Michael Brands et al. Angewandte Chemie International Edition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Franz von Nussbaum Germany 23 1.1k 809 490 353 183 59 2.0k
Daishiro Ikeda Japan 27 1.1k 1.1× 679 0.8× 660 1.3× 273 0.8× 265 1.4× 120 2.0k
Stefan Weigand Germany 16 623 0.6× 651 0.8× 250 0.5× 210 0.6× 114 0.6× 33 1.5k
H. Campbell United States 4 1.5k 1.4× 1.3k 1.6× 399 0.8× 425 1.2× 152 0.8× 4 3.0k
Jiyong Hong United States 33 1.8k 1.7× 1.4k 1.7× 467 1.0× 515 1.5× 372 2.0× 95 3.4k
Shobith Rangappa India 35 1.4k 1.3× 1.2k 1.4× 315 0.6× 655 1.9× 69 0.4× 101 3.1k
Hong‐Chun Liu China 28 1.5k 1.4× 315 0.4× 199 0.4× 212 0.6× 153 0.8× 96 2.3k
Anna Carbone Italy 37 1.0k 1.0× 2.0k 2.5× 192 0.4× 243 0.7× 193 1.1× 95 3.0k
Chakrabhavi Dhananjaya Mohan India 38 1.7k 1.6× 1.1k 1.3× 366 0.7× 794 2.2× 89 0.5× 100 3.7k
Yong Qin China 37 1.5k 1.4× 3.5k 4.3× 341 0.7× 348 1.0× 301 1.6× 181 5.3k
James W. Langley United States 7 1.5k 1.4× 1.3k 1.6× 400 0.8× 430 1.2× 149 0.8× 14 3.1k

Countries citing papers authored by Franz von Nussbaum

Since Specialization
Citations

This map shows the geographic impact of Franz von Nussbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franz von Nussbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franz von Nussbaum more than expected).

Fields of papers citing papers by Franz von Nussbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franz von Nussbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franz von Nussbaum. The network helps show where Franz von Nussbaum may publish in the future.

Co-authorship network of co-authors of Franz von Nussbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Franz von Nussbaum. A scholar is included among the top collaborators of Franz von Nussbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franz von Nussbaum. Franz von Nussbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nising, Carl F. & Franz von Nussbaum. (2022). Industrial Organic Synthesis in Life Sciences – Today and Tomorrow. European Journal of Organic Chemistry. 2022(17). 5 indexed citations
2.
Lemos, Clara, Volker Schulze, Simon J. Baumgart, et al.. (2021). The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models. Cellular Oncology. 44(3). 581–594. 29 indexed citations
3.
Wengner, Antje M., Gerhard Siemeister, Ulrich Lücking, et al.. (2019). The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models. Molecular Cancer Therapeutics. 19(1). 26–38. 145 indexed citations
4.
Siemeister, Gerhard, Anne Mengel, Amaury E. Fernández‐Montalván, et al.. (2018). Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors In Vitro and In Vivo. Clinical Cancer Research. 25(4). 1404–1414. 53 indexed citations
5.
6.
Siegel, Franziska, Antje M. Wengner, Claudia Lange, et al.. (2017). BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activity. Cancer Letters. 390. 21–29. 48 indexed citations
7.
Siemeister, Gerhard, Anne Mengel, Wilhelm Bone, et al.. (2017). Abstract 287: BAY 1816032, a novel BUB1 kinase inhibitor with potent antitumor activity. Cancer Research. 77(13_Supplement). 287–287. 3 indexed citations
8.
Wengner, Antje M., Gerhard Siemeister, Marcus Koppitz, et al.. (2016). Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity. Molecular Cancer Therapeutics. 15(4). 583–592. 85 indexed citations
9.
10.
Nagelschmitz, Johannes, Stephan Schwers, Franz von Nussbaum, et al.. (2014). The novel elastase inhibitor BAY 85-8501 provides a new approach in the treatment of pulmonary diseases. European Respiratory Journal. 44(Suppl 58). 3416–3416. 5 indexed citations
11.
Nagelschmitz, Johannes, et al.. (2014). The novel elastase inhibitor BAY 85-8501: First-in-man study to evaluate safety, tolerability and pharmacokinetics in healthy male subjects. European Respiratory Journal. 44(Suppl 58). P1510–P1510. 2 indexed citations
12.
Nussbaum, Franz von & Guido Schiffer. (2014). Aspergillomarasmin A, ein Inhibitor bakterieller Metallo‐β‐Lactamasen vom bla NDM ‐ und bla VIM ‐Resistenztyp. Angewandte Chemie. 126(44). 11884–11887. 2 indexed citations
13.
Nussbaum, Franz von, Matthias Rüth, Peter Spiteller, et al.. (2011). Coloured Artefacts Formed by Oxidation of Benzene‐1,2,4‐triol and β‐Dopa During the Extraction of Cortinarius violaceus (Agaricales) with Alcohols. European Journal of Organic Chemistry. 2012(2). 380–390. 3 indexed citations
14.
Haebich, Dieter & Franz von Nussbaum. (2009). Lost in Transcription—Inhibition of RNA Polymerase. Angewandte Chemie International Edition. 48(19). 3397–3400. 23 indexed citations
15.
Haebich, Dieter & Franz von Nussbaum. (2007). Platensimycin, a New Antibiotic and “Superbug Challenger” from Nature.. ChemInform. 38(3). 2 indexed citations
16.
Nussbaum, Franz von, Jordi Benet‐Buchholz, Dieter Häbich, et al.. (2007). Structure and Total Synthesis of Lysobactin (Katanosin B). Angewandte Chemie International Edition. 46(12). 2039–2042. 38 indexed citations
17.
Nussbaum, Franz von, Michael Brands, Berthold Hinzen, Stefan Weigand, & Dieter Häbich. (2006). Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?. Angewandte Chemie International Edition. 45(31). 5072–5129. 530 indexed citations breakdown →
18.
Häbich, Dieter & Franz von Nussbaum. (2006). Platensimycin, a New Antibiotic and “Superbug Challenger” from Nature. ChemMedChem. 1(9). 951–954. 79 indexed citations
19.
Spiteller, Peter, Matthias Rüth, Franz von Nussbaum, & Wölfgang Steglich. (2000). Detection of a 2,3-Aminomutase in the MushroomCortinarius violaceus. Angewandte Chemie International Edition. 39(15). 2754–2756. 20 indexed citations
20.
Nussbaum, Franz von, Peter Spiteller, Matthias Rüth, et al.. (1998). An Iron(III)-Catechol Complex as a Mushroom Pigment. Angewandte Chemie International Edition. 37(23). 3292–3295. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daishiro Ikeda Breakdown of academic impact, for papers by Stefan Weigand Breakdown of academic impact, for papers by H. Campbell Breakdown of academic impact, for papers by Jiyong Hong Breakdown of academic impact, for papers by Shobith Rangappa Breakdown of academic impact, for papers by Hong‐Chun Liu Breakdown of academic impact, for papers by Anna Carbone Breakdown of academic impact, for papers by Chakrabhavi Dhananjaya Mohan Breakdown of academic impact, for papers by Yong Qin Breakdown of academic impact, for papers by James W. Langley
Rankless by CCL
2026